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Listeria monocytogenes infected CD8a+ DCs in the
spleen are essential for CD8+ T cell generation.
CD8a+ DCs are also necessary for Listeria expansion
and dissemination within the host. The mechanisms
that regulate CD8a+ DCs to allow Listeria expansion
are unclear. We find that activating the B and T
lymphocyte attenuator (BTLA), a coinhibitory re-
ceptor for T cells, suppresses, while blocking BTLA
enhances, both the primary and memory CD8 T cell
responses against Listeria. Btla/ mice have lower
effector and memory CD8+ T cells while paradoxi-
cally also being more resistant to Listeria. Although
bacterial entry into Btla/ CD8a+ DCs is unaffected,
Listeria fails to expand within these cells. BTLA
signaling limits Fas/FasL-mediated suppression of
Listeria expansion within CD8a+ DCs to more
effectively alert adaptive immune cells. This study
uncovers a BTLA-mediated strategy used by the
host that permits Listeria proliferation to enable
increasing T cell responses for long-term protection.
INTRODUCTION
Listeria monocytogenes is a Gram-positive facultative intra-
cellular bacterial pathogen. It is the causative agent of Listeriosis
that often affects unborn fetuses and immunocompromised
individuals (Dussurget et al., 2004; Kaufmann, 1993). Listeria-
infected animal models are common infectious models to study
systemic immune responses to intracellular pathogens, as
defined innate, effector, and memory responses are essential
to limit Listeria infection (Pamer, 2004). Without an effective
adaptive response to Listeria, infected mice are not able to
survive. This was originally demonstrated by showing that immu-
nodeficient nude, SCID, and Rag1/ mice developed a chronic
Listeria infection and eventually died, while immunocompetent
wild-type (WT) mice cleared the infection (Bancroft et al., 1986;
Emmerling et al., 1975; Mombaerts et al., 1993). Interestingly,
immunodeficient animals harbor lower colony-forming unit
(CFU) levels of splenic Listeria than immunocompetent mice dur-
ing the early phase of infection, indicating that the innate immune
response could function independently of the adaptive immune68 Cell Host & Microbe 16, 68–80, July 9, 2014 ª2014 Elsevier Inc.response to limit early infection (Carrero et al., 2006; Emmerling
et al., 1975). This result further indicated that the adaptive
immune response directly or indirectly regulates the amplitude
of the innate immune response.
As for host adaptive immunity to Listeria, a body of literature
describes the interaction between Listeria infection and the gen-
eration of bacterial-specific CD8+ T cells. Indeed, CD8+ T cells
are required for sterilizing immunity, since b2M/ mice have
shown delayed Listeria clearance (Roberts et al., 1993). Of the
CD8+ T cell functions required for sterilizing immunity, the most
important is the CD8+ T cell cytotoxic function, as perforin-defi-
cient CD8+ T cells cannot control Listeria infection (Jensen et al.,
1998; Ka¨gi et al., 1994; Mittru¨cker et al., 2000; San Mateo et al.,
2002). Upon secondary infection, the ability of the immune sys-
tem to rapidly sterilize the host from Listeria infection is largely
dependent upon the memory CD8+ T cell recall response (Harty
et al., 1992). Listeria infection also induces CD4 T cell responses,
which can help host to control the infection: depleting CD4
T cells will reduce the host immunity against Listeria infection,
while adoptive transferring CD4 T cells from infected mice to
naive mice can provide partial protection (Baldridge et al.,
1990; Kaufmann, 1993; Kaufmann et al., 1985; Ladel et al.,
1994; Mittru¨cker et al., 2000). The role of innate cells during sec-
ondary or memory responses is considered minimum. However,
recent publication showed that the recall response after second
Listeria infection was highly orchestrated by both memory CD8+
T and innate cells: inflammatory Ly6C+ monocytes activate
memory CD8+ T and NK lymphocytes (Soudja et al., 2012), and
cytotoxic memory CD8+ T cells can license inflammatory mono-
cytes and neutrophils to clear Listeria infection (Narni-Mancinelli
et al., 2011). Interestingly, the generation of effective CD8+
memory T cells is dependent upon infection with live but not
heat-killed Listeria (Datta et al., 2006); Listeria needs to enter
the host cell cytosol in order to generate an effective memory
response, as demonstrated by LLO-deficient Listeria that are
unable to induce protective immunity (Berche et al., 1987).
Recently publication has shown that platelet is required for
shuttling Listeria to splenic CD8a+ DCs (Verschoor et al., 2011).
Splenic CD8a+ DCs localize to the marginal zone and efficiently
cross-present viral and intracellular bacterial antigens to CD8+
T cells (Hildner et al., 2008). These CD8a+ DCs are uniquely
dependent upon the transcription factor Batf3 for their develop-
ment (Hildner et al., 2008). The essential role of splenic CD8a+
DCs in CD8+ T cell generation upon Listeria infection has been
demonstrated (Campisi et al., 2011; Mitchell et al., 2011).
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sary for harboring and disseminating Listeria within the host
(Edelson et al., 2011; Neuenhahn et al., 2006). In the spleen,
CD8a+ DCs are the first cells infected with Listeria as early as
1 hr after infection (Verschoor et al., 2011). Confirming that
CD8a+ DCs were necessary for major Listeria expansion and
dissemination, Batf3/ mice were recently demonstrated to
have much lower Listeria burden after infection (Edelson et al.,
2011). Compared with macrophage, CD8a+ DCs are considered
less armed for directly fighting against bacterial or viral infection
but can fascinatingly control listerial proliferation. What molecu-
lar mechanisms regulate function of these cells to allow Listeria
expansion, however, is still unclear.
BTLA signaling in T cells appears to limit T cell responses. We
initially reported that the HVEM delivers signals to suppress
T cell responses and that Hvem/ mice are prone to autoim-
munity (Wang et al., 2005). Others reported that HVEM part-
nered with BTLA inhibited the adaptive immune system (Krieg
et al., 2007; Sedy et al., 2005). HVEM-BTLA interactions also
regulate early immunity through regulating NKT function,
because both Hvem/ and Btla/ mice are hyperresponsive
to NKT-dependent Con A challenge compared to WT mice
(Miller et al., 2009; Wang et al., 2005). We recently observed
that Hvem/ and Btla/ mice have reduced bacterial burden
compared to WT mice in the liver and spleen within 4 days of
Listeria infection (Sun et al., 2009). In this study, Btla/ mice
showed reduced primary and secondary CD8+ T cell responses
upon Listeria infection while being more resistant to Listeria
infection. Rather than directly limiting T cell responses against
Listeria infection, we have now revealed the dominant role of
BTLA signaling during Listeria infection is to permit the expan-
sion of Listeria in CD8a+ DCs in order to induce stronger priming
of T cells.
RESULTS
BTLA Signaling Inhibits Listeria-Specific CD8+ Effector
and Memory T Cell Responses
Previous studies have defined BTLA as a coinhibitory receptor in
T cells that inhibits T cell function through its immunoreceptor
tyrosine-based inhibitory motifs (ITIMs) (Krieg et al., 2007;
Sedy et al., 2005; Watanabe et al., 2003). Our previous data
showed that WT mice treated with the BTLA agonist, HVEM-
Ig, had 2 to 3 logs higher levels of Listeria CFU 3 days after infec-
tion, whereas the antagonistic anti-BTLA mAb consistently
showed suppressed CFU levels, suggesting that the BTLA
pathway inhibits the clearance of Listeria infection (Sun et al.,
2009). BTLA-dependent control of Listeria could be attributed
to both innate and adaptive immunity. To test whether BTLA in-
hibited CD8+ T cell activity, Listeria-OVA-infected mice were
treated with HVEM-Ig to crosslink BTLA, thereby triggering
the BTLA downstream signaling. OVA-specific T cells and the
IFNg production were decreased in mice treated with the BTLA
agonist HVEM-Ig (Figure 1A; Figure S1A available online). To
test whether a BTLA antagonist would increase the T cell
response, we infected mice with a low dosage of Listeria to
better observe an increased responses. Indeed, bacterial-
specific CD8+ T cells and the IFNg production were increased
in mice treated with the anti-BTLA blocking mAb (Figures 1BCand S1B). Therefore, the data suggest that BTLA signaling in
T cells is likely inhibitory, suppressing T cell proliferation during
Listeria infection.
The memory response to Listeria infection is primarily
comprised of the CD8+ T cell and plays a dominant role for clear-
ance of pathogens. Because BTLA has been shown to inhibit the
CD8+ effector response, we expected that BTLA would similarly
inhibit the CD8+ T cell memory response. Indeed, memory CD8+
T cell responses to Listeria infection were severely diminished af-
ter HVEM-Ig crosslinking of BTLA and were significantly
enhanced after BTLA blockade during Listeria second infection
(Figures 1C, 1D, and S1C). Additionally, the Listeria burden cor-
responded to the changes in T cell responses, with reduced
memory T cell responses corresponding to greater Listeria
burden and, vice versa, increased memory T cell responses cor-
responding to much lower bacterial burden (Figure 1E). This
result matches well with the established dogma that CD8+
T cells play a major role in controlling Listeria burden during
both primary and secondary infection and further suggests the
inhibitory role of BTLA in T cells during primary and secondary
Listeria infection.
Anti-Listiera CD8+ T Cell Responses Are Unexpectedly
Reduced in Btla–/– Mice
While transferring to the sameWT recipientmice, BTLA-deficient
T cells are more active and proliferate more than WT T cells in
response to Listeria infection (Krieg et al., 2007). Together with
other studies, it is expected that Btla/ mice should have
increased CD8+ T cell responses during Listeria infection as
compared to WT mice. Surprisingly, we observed that Btla/
mice actually generated significantly fewer CD8+ T cell
responses not only during the primary response but also during
the secondary response to pathogen rechallenge (Figures 2A
and 2B). During different time points after infection, we have
observed the similar reduction of T cell response in Btla/
mice (Figure 2C). Since HVEM is the only known binding partner
for BTLA, we tested whether Hvem/ mice have similar reduc-
tion of T cell responses. Indeed, we observed that T cell genera-
tion in Hvem/ mice is similarly reduced after Listeria infection
(data not shown). In naive mice, there is no difference in CD8
T cell number between WT and Btla/ or Hvem/ mice, sug-
gesting no preexisting deficiency in CD8 T cell numbers (Krieg
et al., 2007). Compared to WT mice, Btla/ mice demonstrated
a much lower Listeria burden concurrent with the lower CD8+
T cell profile during primary responses (Figure 2D).
Memory T cells are known to play a major role for rapid clear-
ance of Listeria during reinfection. We detected much lower
Listeria burden with lower number of memory T cells in Btla/
mice (Figure 2D). However, the T cell responses in Btla/
mice are similar after peptide vaccination (Figure S2). Therefore,
these data suggest that there might be a completely undis-
covered role for the HVEM-BTLA pathway through non-T cells
during the host immune responses to Listeria infection.
BTLA Inhibits the Innate Immune Response to Listeria
Infection
To explore the potential mechanism, we designed several exper-
iments to determine whether BTLA could regulate the innate
immune response independently of the adaptive response. B6ell Host & Microbe 16, 68–80, July 9, 2014 ª2014 Elsevier Inc. 69
(legend on next page)
Cell Host & Microbe
BTLA Allows Listeria Proliferation inside CD8a+ DCs
70 Cell Host & Microbe 16, 68–80, July 9, 2014 ª2014 Elsevier Inc.
Cell Host & Microbe
BTLA Allows Listeria Proliferation inside CD8a+ DCsRag1/mice were crossed toBtla/ andHvem/mice to pro-
duce Btla/Rag1/ and Hvem/Rag1/ mice to avoid the
influence of adaptive immune system. To directly test whether
HVEM and BTLA inhibit the innate immune response, we
infected both DKO mice with Listeria and monitored the mice
for survival. We found that both Btla/Rag1/ and Hvem/
Rag1/ mice survived longer than Rag1/ controls and with
lower bacteria burden (Figures 3A, 3B, S3A, and S3B), indicating
that HVEM and BTLA do inhibit innate immune responses to
intracellular Listeria infection.
To further determine whether BTLA signaling in innate cells by
HVEM interaction is required for the innate response to Listeria
infection, we treated Rag1/ mice with HVEM-Ig to activate
BTLA signaling. We did find that Listeria burden was elevated
after HVEM-Ig treatment (Figure 3C). Taken together, these
data suggest that HVEM and BTLA have an undiscovered role
on regulating the innate response to Listeria.
BTLA Promotes Proliferation of Listeria in CD8a+ DCs
for Better CD8+ T Cell Responses
Since BTLA in T cells inhibits T cell activity, this paradigm cannot
account for our unexpected finding that the T cell response is
reduced in the absence of BTLA in both T and innate cells. There-
fore, we hypothesized that BTLA could be regulating non-T cells
that help generating the T cell responses, such as the APCs. To
test this hypothesis, we adoptively transferred WT splenocytes
to Rag1/ and Btla/Rag1/ mice and infected these mice
14 days later to avoid homeostasis induced activation. In these
reconstituted mice, only the expression of BTLA in innate cells
were different, not T cells. We compared the bacterial-specific
T cell responses 7 days after infection, and Btla/Rag1/
mice showed dramatically decrease of T cell response
compared with Rag1/ mice (Figure 4A), suggesting that
BTLA in innate cells is required for T cell responses. To further
define which type of innate cells is responsible for the decreased
T cell responses, we isolated DCs, the major APCs for Listerial
antigen presentation, from Listeria-OVA-infectedWT andBtla/
mice and incubated with naive OT-I T cells. We found that total
DCs from Btla/mice have reduced OT-I T cell activation ability
(data not shown). Since CD8a+ DCs are the major DC type for
priming CTL responses, we further revealed that CD8a+ DCs
from Btla/ mice are less efficient at cross-presenting Listerial
antigen to CD8+ T cells resulting in less ability to induce T cell
proliferation and IFN-g production (Figure 4B).
The CD8a+ DC was shown to be early and essential site for
replication of Listeria, and replication in these DCs was essential
for the induction of anti-Listeria CTL responses (Edelson et al.,Figure 1. BTLA Inhibits Bacteria-Specific CD8+ Effector and Memory T
(A) CFSE-labeled pooled splenocytes and LN cells isolated from OTI/Thy1.1 mi
recipients were immunized with 53 105 CFU Listeria-OVA and treated with 200 mg
Thy1.1+ CD8+ OVA-tetramer+ cells and intracellular IFNg were analyzed by flow
(B) CFSE-labeled pooled splenocytes and LN cells isolated fromOTI/Thy1.1mice
immunized with low-dosage 13 105 CFU Listeria-OVA and treated with 200 mg an
Thy1.1+ CD8+ OVA-tetramer+ cells and intracellular IFNg were analyzed by flow
(C and D) (C) WT mice were primarily infected i.p. with 13 104 CFU Listeria-OVA.
treated with 200 mg HVEM-Ig or mIgG (C), Hamster Ig, or anti-BTLA (6A6) Ab (D). S
cells and intracellular IFNg were analyzed by flow cytometry.
(E) Same as in (C), 3 days after rechallenge, the bacteria burden in the splee
experiments, four to five mice in each group, and data are represented as mean
C2011; Verschoor et al., 2011). Since BTLA-deficient CD8a+
DCs express even more MHCII and CD86 after infection
(Figure S4A), the lower T cell activation ability is not due to DC
activation status, which raises the possibility of lower antigen
load in BTLA-deficient CD8a+ DCs. Critical to CD8a+ DC func-
tion, the platelet was recently shown to be essential for
shuttling Listeria from the blood into the CD8a+ DCs (Edelson
et al., 2011; Verschoor et al., 2011).
Initially, we asked whether BTLA could affect the trafficking of
Listeria from the blood into CD8a+ DCs by means of the platelet.
However, the platelet binding ability to Listeriawas not altered in
Btla/ mice (Figure S4C). Then we asked whether BTLA could
affect the replication of Listeria within CD8a+ DCs, the major
infected population of splenocytes, which might further affect
the CD8+ T cell activation by impacting the antigen level. In order
to detect the proliferation of Listeria in CD8a+ DCs in short time
runs, we use intravenous infection instead of previously used
intraperitoneal infection. When we checked the Listeria count
in CD8a+ DCs 16 hr after infection, we found more than a
5-fold increase in Listeria CFU per CD8a+ DC from WT mice
than that from Btla/ mice (Figures 4C, right panel, and S4B).
There were no difference in Listeria CFU within neutrophils
and macrophages. This suggested that BTLA is playing a previ-
ously unrecognized role on expanding Listeria inside those
specialized DCs.
To determine when and where the Listeria burden was
affected through BTLA, we traced the difference to as early as
1 hr after infection (Figure 4C, middle panel). Furthermore, there
was no difference in Listeria count within CD8a+ DC sooner than
1 hr after infection between WT and Btla/ mice (Figure 4C, left
panel). This suggested that there is no defect in pathogen entry
into CD8a+ DCs in Btla/ mice. Not only on a per cell basis was
the Listeria burden reduced, but also the total Listeria burden in
the entire organ was reduced in Btla/ mice (Figure 4D). We
observed similar results when HVEM-BTLA interaction was
affected in Rag1/ background or after low-dosage infection
(data not shown). Therefore, BTLA as the classically inhibitory
molecule for T cells could have an opposite role in regulating
CD8a+ DCs to promote the pathogen proliferation that domi-
nantly enhances T cell responses, rather than inhibiting T cell
responses directly through its ITIMs.
BTLA Intrinsically Regulates the Function of CD8a+ DCs
during Listeria Infection
Since there is lower Listeria CFU level per CD8a+ DC within
16 hr after infection, and there is no reduction of total number
of CD8a+ DCs in the spleen of Btla/ mice (De Trez et al.,Cell Responses
ce (2 3 107 cells) were adoptively transferred into WT Thy1.2+ mice, and the
HVEM-Ig or mIgG as control. Seven days later, splenocytes were isolated, and
cytometry.
(23 107 cells) were adoptively transferred intoWTmice, and the recipientswere
ti-BTLA (6A6) or hamster IgG. Seven days later, splenocytes were isolated, and
cytometry.
Two months later, mice were rechallenged with 53 106 CFU Listeria-OVA and
ix days later, splenocytes were isolated, and endogenous CD8+ OVA-tetramer+
n and liver was tested. The results are representative of three independent
±SEM. See also Figure S1.
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Figure 2. Btla–/– Mice Have Lower CD8 T Effector and Memory Cell Generation
(A) WT and Btla/ mice were infected i.p. with 5 3 105 CFU Listeria-OVA. Seven days later, splenocytes were isolated, and endogenous CD8+ OVA-tetramer+
cells were analyzed by flow cytometry.
(B) WT and Btla/ mice were primarily infected i.p. with 1 3 104 CFU Listeria-OVA. Two months later, mice were rechallenged with 5 3 106 CFU Listeria-OVA.
Seven days later, splenocytes were isolated and, endogenous CD8+ OVA-tetramer+ cells and intracellular IFNg were analyzed by flow cytometry.
(C) Same as in (A), 10 and 20 days after infection, splenocytes were isolated, and endogenous CD8+ OVA-tetramer+ cells were analyzed by flow cytometry.
(D) Same as in (A) and (B), 3 days after infection the bacteria burden in the spleen and liver was tested. The results are representative of five independent
experiments, four to five mice in each group, and data are represented as mean ±SEM. See also Figure S2.
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Figure 3. BTLA Inhibits Innate Immune Response to Listeria Infection
(A and B) Rag1/ and Rag1/ Btla/ (A) or Rag1/Hvem/ (B) mice were infected i.p. with 1 3 106 CFU Listeria-OVA, and mice survival was observed.
(C) Rag1/ mice were infected i.p. with 1 3 106 CFU Listeria-OVA and treated with 200 mg of mouse IgG or HVEM-Ig. Seven days later, the bacteria burden in
spleen and liver was tested. The results are representative of three independent experiments, five to seven mice in each group, and data are represented as
mean ±SEM. See also Figure S3.
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BTLA Allows Listeria Proliferation inside CD8a+ DCs2008), BTLA could directly control the function of CD8a+ DCs.
To address whether BTLA can directly regulate the CD8a+
DCs, we first asked whether BTLA is selectively expressed in
this type of DC. Indeed, BTLA is selectively highly expressed
in CD8a+ DCs but not in other DC subtypes (Figure 5A), which
is consistent with previous observation (De Trez et al., 2008). In
that study, they focused on the regulatory role of HVEM-BTLA
in DC homeostasis. To study whether BTLA signaling in
CD8a+ DCs is required for the proliferation of Listeria, we
targeted BTLA in WT mice to determine whether functional
blockade of BTLA could influence Listeria replication within
CD8a+ DCs similarly to the Btla/ mice. We treated mice
with the BTLA blocking mAb (clone 6A6) during infection and
found that BTLA signaling blockade indeed affected the replica-
tion of Listeria in CD8a+ DCs (Figure 5B). The similar result was
observed when mice are treated with another BTLA blocking
mAb (clone 6F7, data not shown). These data suggest that
the BTLA-mediated signaling in CD8a+ DCs is required for func-
tionally regulating the replication of Listeria in these DCs. To
further test whether replication of Listeria is through CD8a+
DCs intrinsic mechanism, we constructed mixed bone marrow
chimera mice. We transferred CD45.1+ WT and CD45.2+ Btla/
BM to WT recipient mice (Figure 5C). After infection with
Listeria, we sorted out WT and Btla/ CD8a+ and CD8a
DCs from the same recipient mice and compared the Listeria
burden in these cells. We found that there were much fewer
Listeria in Btla/ CD8a+ DCs than WT CD8a+ DCs (Figure 5D).
Furthermore, there is no difference in Listeria burden in CD8aCDCs (Figure 5D). These data suggest that BTLA regulates the
function of CD8a+ DCs intrinsically. This conclusion was further
proven by the in vitro Listeria infection assay in sorted (>98%
purity) CD8a+ DCs. Anti-BTLA blocking Ab treatment
decreased the proliferation of Listeria in this single sorted cell
population (Figure 5E).
FasL and Fas Expression Induced by Listeria Infection
Is Inhibited by BTLA in CD8a+ DC
Since our data showed that the BTLA promotes the proliferation
of Listeria in CD8a+ DCs, we next asked whether BTLA could
regulate specific pathways involving CD8a+ DCs that might influ-
ence intracellular bacterial proliferation. Since BTLA is cloned
from apoptotic thymocytes (Han et al., 2004), we wondered
whether BTLA could regulate apoptosis-associated molecules,
such as TNF and Fas/FasL. We did not see any difference for
TNF production (data not shown). Impressively, we have
observed that the most prominent alteration was a 7-fold
increase in FasL transcripts in CD8a+ DCs from Btla/ mice
compared with WT mice after Listeria infection (Figure 6A). In
contrast, no significant changes were observed in mRNA levels
of FasL in CD8a DCs derived from Btla/ and WT mice (Fig-
ure 6A). Since HVEM is the only known binding partner of
BTLA, we also compared the FasL and Fas expression in
CD8a+ DCs from Hvem/ mice and WT mice. Similarly with
Btla/ mice, CD8a+ DCs from Hvem/ mice showed about
40 times increased expression of FasL after Listeria infection
(Figure S5A). Since SHP-1 and SHP-2 are downstream ofell Host & Microbe 16, 68–80, July 9, 2014 ª2014 Elsevier Inc. 73
Figure 4. BTLA Promotes Proliferation of Listeria in CD8a+ DCs for Better CD8+ T Cell Responses
(A) Rag1/ and Rag1/ Btla/ mice were adoptively transferred with 2 3 107 WT splenocytes. Fourteen days later, mice are infected with Listeria-OVA, and
OVA-specific T cell responses were detected 7 days after infection.
(B) WT and Btla/ mice were infected i.v. with 1 3 107 Listeria-OVA. Sixteen hours after infection, sorted splenic CD8a+ DCs were incubated with purified
OVA-specific OT-I T cell. 3H-thymidine was pulsed in the last 18 hr of a 3 day culture, and cells were harvested for liquid scintillation counting. IFN-g production in
the supernatant was measured on day 2 of the culture.
(C) WT andBtla/mice were infected i.v. with 13 107 Listeria-OVA. Thirty minutes, 1 hr, and 16 hr after infection, splenic PMN andmacrophage, CD8a+ DC, and
CD8a DC populations were purified by flow sorting, and sorted populations were lysed and plated onto BHI agar to determine degree of infection.
(D) Total ListeriaCFU inCD8a+ DCper spleenwas shown from the same experiment as (C). The results are representative of three independent experiments, three
to five mice in each group, and data are represented as mean ±SEM. See also Figure S4.
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BTLA Allows Listeria Proliferation inside CD8a+ DCsBTLA signaling for suppressing T cells activation, we wondered
whether BTLA uses the same pathway to regulate the expression
of FasL. As shown in Figure S5B, inhibiting SHP-1 and SHP-2 by
two specific inhibitors could mimic BTLA-deficiency-induced
FasL upregulation during Listeria infection. In this assay, there
is no exogenous signal for activating BTLA. We think that the
interaction between endogenous HVEM-BTLA is responsible
for the activation of BTLA signaling in the steady status.
To specifically address whether the HVEM-BTLA signaling
pathway regulates at the functional rather than developmental74 Cell Host & Microbe 16, 68–80, July 9, 2014 ª2014 Elsevier Inc.level, we targeted this pathway in CD8a+ DCs from WT mice
using the antagonistic anti-BTLA mAb during Listeria infection.
Consistently, the anti-BTLA antibody increased the expression
of FasL during Listeria infection (Figure 6B). To further prove
that the upregulation of FasL in CD8a+ DCs from Btla/ mice
counts for the lower Listeria proliferation, we blocked the FasL-
Fas interaction by a blocking anti-FasL antibody to see whether
it would rescue the proliferation of Listeria in BTLA-deficient
CD8a+ DCs. Indeed, after treatment with anti-FasL antibody,
Listeria proliferation was elevated in BTLA-deficient CD8a+
Figure 5. BTLA Directly Affects the Function of CD8a+ DCs
(A) The expression of BTLA and HVEM in CD8a and CD8a+ DCs from naive WT, Btla/, and Hvem/ mice was analyzed by flow cytometry.
(B)WTmicewere treatedwith Hamster IgG or anti-BTLA (6A6) Ab and infected i.v. with 13 107 Listeria-OVA 30minutes later. Sixteen hours after infection, splenic
PMN and macrophage, CD8a+ DC, and CD8a DC populations were purified by flow sorting, and sorted populations were lysed and plated onto BHI agar to
determine degree of infection.
(C) Schematic of the mixed BM chimera experiments.
(D) WT mice were lethally irradiated (10 Gy) and transferred with mix bone marrow (CD45.1 WT and CD45.2 Btla/ BM). Two months after reconstitution, mice
were infected i.v. with 5 3 106 Listeria-OVA. Sixteen hours after infection, indicated sorted cell populations were lysed and plated onto BHI agar to determine
degree of infection.
(E) Sorted CD8a+ DCs fromWT were infected with Listeria-OVA for 0.5 hr. Free bacteria were removed by Percoll gradient centrifugation. Cells were cultured for
another 4 hr in the presence of hamster Ig or anti-BTLA (6A6) Ab. At indicated time, cells were lysed and plated to BHI agar to determine degree of infection. The
results are representative of two or three independent experiments, three to five mice in each group, and data are represented as mean ±SEM.
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Listeria expansion inside CD8a+ DCs, Fas/mice were infected
with Listeria. Indeed, the Listeria level in CD8a+ DCs from Fas/
mice is elevated compared WT mice (Figure 6D). These data
suggest that the HVEM-BTLA interaction is required for the sup-
pression of the expression of FasL and Fas, which is responsible
for the lower Listeria proliferation in BTLA-deficient CD8a+ DCs.CDISCUSSION
The current dogma is that HVEM-BTLA signaling inhibits T cell
function (Krieg et al., 2007; Sedy et al., 2005; Sun et al., 2009;
Wang et al., 2005). We have now demonstrated that crosslinking
BTLA by HVEM suppresses T cell responses against Listeria,
while blocking BTLA enhances both primary and memory T cellell Host & Microbe 16, 68–80, July 9, 2014 ª2014 Elsevier Inc. 75
Figure 6. BTLA Inhibits the Expression of FasL and Fas during Listeria Infection
(A) Sorted splenic CD8a+ and CD8a DCs from WT and Btla/ mice were infected with Listeria-OVA in vitro for 6 hr. The expression level of fasL and fasmRNA
was analyzed by quantitative real-time PCR.
(B) Sorted splenic CD8a+ DCs fromWT were infected with Listeria-OVA for 6 hr in the presence of hamster Ig or anti-BTLA (6A6) Ab. The expression level of fasL
and fas mRNA was analyzed by quantitative real-time PCR. The results are representative of three independent experiments.
(C) Btla/ mice were infected i.v. with 1 3 107 Listeria-OVA and treated with hamster Ig or anti-FasL Ab. Sixteen hours after infection, splenic PMN and
macrophage, CD8a+ DC, and CD8a DC populations were purified by flow sorting, and sorted populations were lysed and plated onto BHI agar to determine
degree of infection.
(D) WT and Fas/ mice were infected i.v. with 1 3 107 Listeria-OVA. Sixteen hours after infection, splenic PMN and macrophage, CD8a+ DC, and CD8a DC
populations were purified by flow sorting, and sorted populations were lysed and plated onto BHI agar to determine degree of infection. The results are
representative of two independent experiments, four mice in each group, and data are represented as mean ±SEM. See also Figure S5.
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strated that Btla/ and Hvem/ mice exhibited lower Listeria
burden than WT mice during the early or memory phase of
infection. Therefore, we expected that Listeria-specific CD8+
T cells would be increased in Btla/ and Hvem/ mice after
Listeria infection. To our surprise, Ag-reactive CD8+ T cells
were instead reduced in both knockout strains after infection.
Intriguingly, the data raised the possibility that the HVEM-BTLA
pathway through non-T cells play a dominant role in generation
of T cell responses after Listeria infection.
We have further demonstrated that the BTLA pathway controls
the function of CD8a+ splenic DCs, thereby increasing the load of
intracellular pathogen within the host for improved T cell priming.
(1) BTLA signaling can impact the innate immune response in
addition to its classically known role on the adaptive immune
response: Btla/Rag1/ and Hvem/Rag1/mice survived
longer than the Rag1/ controls. (2) Direct BTLA signaling con-
trols the function of CD8a+ DCs: the proliferation of Listeria per
CD8a+ DC in Btla/ mice was lower than in WT mice, resulting
in less antigenic load for priming the CD8+ T cell response. (3)
BTLA in CD8a+ DCs regulated the expression of FasL and Fas
in DCs, especially after Listeria infection, which could be respon-
sible for the reduced proliferation of Listeria in CD8a+ DCs from
Btla/ mice. Therefore, we propose a role for the HVEM-BTLA
pathway. Unexpectedly, the HVEM-BTLA coinhibitory pathway
for T cells regulates APCs to permit early expansion of intracel-
lular pathogens that enhances the sensing of infection by T cells.
Recently, it was reported that lymphotoxin from the B cell
could promote vesicular stomatitis virus (VSV) replication in
subcapsular sinus (SCS) macrophages, which produce type I
interferons to control lethal VSV central nervous system invasion
(Moseman et al., 2012). In this case, SCS macrophages function
as a ‘‘necessary evil’’ to permit short-term survival of virus in or-
der to promote long-term immunity of the host. This example and
our current study present an overarching strategy used by the
host to achieve maximum survival at the cost of early local
expansion of pathogens. If we consider that the host more
frequently encounters sublethal doses of bacterial pathogens,
the host innate response can control these lower dosage infec-
tions. By permitting the controlled expansion of pathogen in
CD8a+ DCs, the host can better alert CD8+ T cells, leading to
proper T cell memory responses. Therefore, the host will be
better prepared to clear higher dosage infections that would
otherwise be lethal in the future. When we infected mice with
as low as 10 CFUs of Listeria to test this idea, we discovered
that we could still detect the CD8+ T cell responses in WT
mice, but not in Btla/ and Hvem/ mice (data not shown).
This suggested that the host innate response can utilize the
HVEM-BTLA pathway to permit Listeria expansion inside a key
APC in order to amplify this sublethal signal for priming a stron-
ger adaptive response to protect against future lethal infections.
It will be also exciting to determine whether various innate cells
can host distinct pathogens for better alerting host or protecting
vital host organs to promote overall survival.
More recently, platelets have been shown to acquire Listeria in
the bloodstream after intravenous administration of Listeria and
are required to rapidly transport the Listeria directly to the splenic
CD8a+ DCs (Verschoor et al., 2011). Our data indicates that
BTLA deficiency doesn’t impact the platelet-mediated transport-Cing of Listeria from blood to splenic CD8a+ DCs. However, the
proliferation of Listeria in CD8a+ DCs is dramatically reduced in
Btla/ mice. Therefore, it raises the possibility that BTLA might
be required to permit Listeria expansion within the CD8a+ DCs. It
is at first counterintuitive to imagine why the immune system
would evolutionarily preserve this function of BTLA to promote
the dissemination of bacteria. We would argue that this same
regulation of BTLA in CD8a+ DCs actually promotes a mecha-
nism that generates an optimal CD8+ T cell recall response
that is required to protect the host from future lethal infections.
Specifically, BTLA signaling permits more Listeria expansion,
which can help the antigens to be presented more efficiently,
thereby facilitating the generation of stronger effector and
memory CD8+ T cell responses.
The Fas pathway has long been considered a critical regulator
of T cell homeostasis and T cell apoptosis after activation, as
deficiency in the Fas pathway causes dysregulated lympho-
proliferation leading to autoimmune diseases (Adachi et al.,
1996; Takahashi et al., 1994). This pathway involving Fas/FasL
might play an additional role in the homeostasis of innate cells.
Our study has now revealed that the BTLA pathway regulates
Fas and FasL expression that might be important to control
Listeria load in infected CD8a+ DCs. It has been reported that
Fas signaling in DCs controls DC accumulation and can curtail
autoimmune diseases (Chen et al., 2006, 2012; Stranges et al.,
2007). We have observed that that BTLA-deficient CD8a+ DCs
express more FasL after LPS or CpG stimulation (data not
shown). However, the difference is not as dramatic as Listeria
infection, suggesting the impact on TLR signalingmay contribute
partially to the DC function. Whether the Fas pathway controls
the survival of CD8a+ DCs upon Listeria infection remains to be
determined. Another possibility is that Fas signaling directly sup-
presses Listeria proliferation inside these DCs. BTLA is highly
expressed by CD8a+ DCs, but not by other DC subtypes, which
correlates with the regulatory function of BTLA in these DCs. It
will be interesting to further dissect how BTLA signaling regu-
lates the expression of Fas/FasL and whether there are multiple
cross-talks happening between the T cell and CD8a+ DC
involving BTLA, HVEM, and the other binding partners that
regulate the innate and adaptive immune responses against
intracellular bacterial infections. It would also be interesting to
determine whether these interactions happen in cis or trans.
Rather than reduced response, Kaye’s group had previously
shown enhanced T cell responses against Listeria due to BTLA
deficiency. In that study, T cells from both WT and Btla/
mice were transferred into the same WT recipient, resulting in
BTLA deficiency only in T cells but not in non-T cells such as
CD8a+ DCs (Krieg et al., 2007). However, in our current experi-
ments, Btla/ mice, lacking BTLA in both CD8a+ DCs and
T cells, have less bacterial-specific T cell response after Listeria
infection due to fewer Listeria expansion inside those DCs.
Overall, those mice have lower Listeria burden. Together, this
indicated a dominant role of BTLA is to enhance listerial ex-
pansion in CD8a+ DCs that lead to enhance overall T cell
response during Listeria infection, whereas the inhibitory func-
tion of BTLA in T cells plays a minor role.
Thus, BTLA has dual roles in controlling the host response
against intracellular pathogens. First, BTLA in CD8a+ DCs can
control antigen load by regulating the function of splenicell Host & Microbe 16, 68–80, July 9, 2014 ª2014 Elsevier Inc. 77
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sponses. Second, BTLA in T cells can modulate the amplitude
of T cell activation. Our study provides evidence that a coinhibi-
tory pathway for T cells could play an opposite role to increase
overall T cell responses by permitting pathogen proliferation
within specialized DCs. On the other hand, BTLA in T cells might
be needed to temper overreactive T cell responses to reduce
tissue injury. Targeting BTLA in different cells could potentially
be used therapeutically regulate the complementary innate and
adaptive immune responses during different infectious condi-
tion. In high-dosage lethal infections, blocking BTLA in CD8a+
DCs could reduce initial proliferation of pathogens, while
blocking BTLA in CD8+ T cells could increase antibacterial CTL
responses. In low-dosage sublethal infections, engaging BTLA
to increase antigen load may be more efficient for the host to
prime memory responses against lethal infections in the future.
It will be exciting to study whether BTLA signal in innate cells is
essential for other intracellular pathogen infections and whether
other coinhibitory signals play similar balanced roles for fine
tuning the sensitivity and amplitude of T cell responses during
pathogen infection.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6J (referred as WT) and Thy1.1 congenic mice were purchased from
The Jackson Laboratory. Hvem/ (Wang et al., 2005) and Btla/ mice (Han
et al., 2004)were generated as previously described. OTI CD8+ TCR transgenic
mice (generously provide by William R. Heath, The Walter and Eliza Hall
Institute of Medical Research, Melbourne) were bred with B6/Thy1.1 to obtain
OTI/Thy1.1 congenic TCR transgenic mice. All mice were maintained under
specific pathogen-free conditions. Animal care and use were in accordance
with institutional and NIH protocols and guidelines, and all studies were
approved by the Animal Care and Use Committee of the University of Chicago.
Peptide, Fusion Protein, Antibodies, and Flow Cytometry
OVA257–264 (SIINFEKL) peptides were synthesized at the University of Chicago
Peptide Core facility. Mouse HVEM-Ig fusion protein (Wang et al., 2005) and
blocking anti-BTLA monoclonal antibody (clone 6A6, hamster IgG) (Hurchla
et al., 2005) were generated as previously described. Mouse IgG and hamster
IgG (SigmaChemical Co.) were used as controls for HVEM-Ig and 6A6, respec-
tively. iTAgMHC Tetramer (SIINFEKL-H-2Kb-PE, referred as OVA-tetramer)
was purchased from Beckman Coulter. The other fluorescent-conjugated
antibodies were purchased from BD Bioscience or Biolegend. Single-cell sus-
pensions of cells were incubated with anti-CD16/32 (anti-FcgIII/II receptor,
clone 2.4G2) for 10 min and then subsequently stained with conjugated anti-
bodies. Dead cells are excluded by 7-AAD staining. The stained cells were
analyzed by flow cytometry using a FACS Caliber or FACS Canto (BD Biosci-
ence). The collected data were analyzed by Flowjo software (Tree Star).
Listeria Infection, Treatment, and Determination of CFU
The recombinant Listeria strain Listeria-OVA, which secretes OVA was pro-
vided by Chyung-RuWang (Northwestern University, Chicago) and was grown
in brain-heart infusion broth (Difco Laboratories). For titration of bacterial load
in tissues, WT and various knockout mice were infected intraperitoneally (i.p.)
with indicated CFU of Listeria-OVA. The bacterial dose was verified by plating
dilutions of the inoculum on brain-heart infusion agar plates. To block or
engage BTLA pathway, mice were administered with 200 mg of anti-BTLA
(6A6) or 200 mg of HVEM-Ig by i.p. injection on the same day but before infec-
tion. On indicated day after infection, mice were sacrificed, and specimens of
spleen and liver were examined for bacterial titers. In brief, organs were
homogenized and lysed in sterile water with 0.5% Triton X-100, serial dilutions
of homogenates were plated on brain-heart infusion agar plates, and colonies
were counted after incubation at 37C for 24 hr.78 Cell Host & Microbe 16, 68–80, July 9, 2014 ª2014 Elsevier Inc.Monitoring Antigen-Specific CD8+ T cell In Vivo
Pooled splenocytes and lymph node (LN) cells were isolated from OTI/Thy1.1
mice and labeled with 10 mM carboxyfluorescein diacetate succinimidyl ester
(CFSE) (Molecular Probes) at 37C for 30 min. CFSE-labeled cells were adop-
tively transferred into WT mice at 2 3 107 cells/mouse by intravenous (i.v.)
injection, and the recipients were then infected with 1 3 105 or 5 3 105 CFU
of Listeria-OVA and treated with anti-BTLA or HVEM-Ig, respectively, as indi-
cated. Three days later, splenocytes were isolated for both surface makers
and intracellular IFN-g staining. Briefly, splenocytes from naive or Listeria-
OVA-infected mice were cultured in 24-well plates at a concentration of 2 3
106 cells/well in the presence or absence of 1 mg/ml OVA257–264 for 5 hr. For
the last 3 hr of stimulation, monensin (final concentration of 10 mM) was added
to block the secretion of cytokines. Cells were washed and stained for cell
surface markers. After fixation with 4% paraformaldehyde and permeabiliza-
tion with 0.15% saponin, cells were then stained with anti-IFN-g antibody.
Memory Responses after Listeria-OVA Infection
WT or various knockout mice were primarily infected i.p. with 1 3 104 CFU
Listeria-OVA. Two months later, mice were rechallenged with 5 3 106 CFU
Listeria-OVA and treated with 200 mg HVEM-Ig or mIgG, Hamster Ig, or anti-
BTLA (6A6) Ab. Six days later, splenic endogenous CD8+ OVA-tetramer+ cells
and intracellular IFNg were analyzed by flow cytometry.
Generation of Bone Marrow Chimeras
WT mice were lethally irradiated with a single dose of 10 Gy. The next day,
irradiated mice were adoptively transferred i.v. with 1:1 mixed 2 3 106 WT
(CD45.1+) and Btla/ (CD45.2+) donor bone marrow cells. Mice were main-
tained on sulfamethoxazole and trimethoprim (Bactrim) antibiotics diluted in
drinking water for 4 weeks after reconstitution. Mice were infected with Listeria
60–70 days later.
Listeria Burden in CD8a+ DC
For experiments involving splenic cell sorting, mice were infected intrave-
nously with 1 3 107 CFU Listeria-OVA, and spleens were collected after
0.5 hr, 1 hr, and 16 hr after infection. Spleens were digested with 1 mg/ml of
collagenase VIII (Sigma Chemical Co.) and 0.2 mg/ml of DNase I (Sigma
Chemical Co.) at 37C for 20 min. Red blood cells were lysed by ACK buffer.
Cells were washed once with 5 mg/ml gentamicin in PBS for 3 min. Cells
were enriched by CD11c-PE selection Kit (Stemcell), and splenic
CD11cloCD11b+ granulocyte (PMN) and macrophage (M4, including mono-
cytes), CD11chigh CD8a+ (CD8a+ DCs), and CD11c+ CD8a (CD8a DCs)
populations were purified by flow sorting with FACS AriaII (BD Bioscience).
Sorted populations (About 100,000 cells for CD8a+ DC, 200,000 cells for
CD8 a DC, and 800,000 cells for PMN and macrophage) were lysed and
plated onto BHI agar. The degree of infection was calculated by dividing
CFU numbers with cell numbers.
FasL and Fas mRNA Expression Detection
Sorted splenic CD8a+ and CD8a DC from WT, Btla/, and Hvem/ mice
were infected with Listeria-OVA in vitro for 6 hr. Total RNA was isolated by
RNeasy mini kit (QIAGEN) and reverse transcripted to cDNA by Sensiscript
RT kit (QIAGEN).The expression level of fasL and fas mRNA was analyzed
by quantitative real-time PCR. The primers used for the assay are the following:
FasL, 50-AGAAGAAGGACCACAACACAAATC, 50-TCACGGAGTTCTGCC
AGTTC;
Fas, 50-TGCGATTCTCCTGGCTGTG, 50-TTGTATTGCTGGTTGCTGTGC;
b-actin, 50-ACACCCGCCACCAGTTCGC, 50-ATGGGGTACTTCAGGGTCA
GGATA.
Cytokine Analysis
Cytokine production from the culture supernatant was measured by mouse
inflammation cytokine beads array kit according to the manufacturer’s
protocol (BD Bioscience).
In Vitro T Cell Stimulation Assay by DCs
WT and Btla/ mice were infected i.v. with 1 3 107 Listeria-OVA. Sixteen
hours after infection, 5 3 104 sorted splenic DCs or CD8a+ CD11c+ DCs
Cell Host & Microbe
BTLA Allows Listeria Proliferation inside CD8a+ DCswere incubated with 23 105 purified OT-I T cells for 2 days, pulsed with 1 mCi
of 3H-thymidine for 18 hr, and harvested for liquid scintillation counting.
Statistical Analysis
Mean values were compared using an unpaired Student’s two-tailed t test.
Error bars represent SD or SEM. Statistically significant differences p < 0.05
and p < 0.01 are noted with * and **, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
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